These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6069635)

  • 21. The biophysical effects of insulin-releasing agents on islet cells.
    Matthews EK; Dean PM
    Postgrad Med J; 1970 Dec; ():Suppl:21-3. PubMed ID: 5500512
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experiences with tolazamide].
    Laffi GC; Bruno GM
    Minerva Med; 1965 Sep; 56(75):3213-5. PubMed ID: 5320010
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tolazamide and hepatic damage].
    Ferrero E; Marioni G; Antognetti R; Falchi F
    Minerva Med; 1965 Oct; 56(85):3609-13. PubMed ID: 5841666
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with the oral antidiabetic compound, tolazamide.
    McKendry JB; Gfeller KF
    Can Med Assoc J; 1967 Mar; 96(9):531-5. PubMed ID: 6019353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of improved glycaemic control with chlorpropamide on microvascular reactivity and nitric oxide synthase activity in diabetic rats.
    Sartoretto JL; Santos RA; Scavone C; Tostes RC; Nigro D; Carvalho MH; Cuman RK; Fortes ZB
    J Pharm Pharmacol; 2007 Aug; 59(8):1117-23. PubMed ID: 17725854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of succinylcholine to chlorpropamide-induced hypoglycemia.
    JAEGER DA; DRAKONTIDES AB; DIMITRAKIS M; SCHNEIDER JA
    Proc Soc Exp Biol Med; 1959 Jul; 101(3):532-5. PubMed ID: 13675307
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypogycaemia without coma.
    Saha B
    J Indian Med Assoc; 2007 Feb; 105(2):99. PubMed ID: 17822180
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypoglycemic potency in man of a new sulfonylurea derivative (chlorpropamide).
    WEST KM; McCAMPBELL SR
    Proc Soc Exp Biol Med; 1958; 98(4):724-5. PubMed ID: 13591321
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.
    Sketris IS; Kephart GC; Frail DM; Skedgel C; Allen MJ
    Pharmacotherapy; 2004 Jun; 24(6):784-91. PubMed ID: 15222669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects on intrathyroid hormonal metabolism in rats, of some derivatives of sulfonylurea used as hypoglycemic agents].
    Guazzelli R; Conti C; Bigazzi M
    Acta Diabetol Lat; 1968; 5(4):614-23. PubMed ID: 5720639
    [No Abstract]   [Full Text] [Related]  

  • 31. Chlorpropamide toxicity with survival despite 27-day hypoglycemia.
    Ciechanowski K; Borowiak KS; Potocka BA; Nowacka M; Dutkiewicz G
    J Toxicol Clin Toxicol; 1999; 37(7):869-71. PubMed ID: 10630272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chlorpropamide hyponatremia on mental status in a nursing home population.
    Sloan RW; Kreider RM; Luderer JR
    J Fam Pract; 1983 May; 16(5):937-42. PubMed ID: 6842150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolazamide proves valuable as oral hypoglycemic agent.
    Delgado JN; Cosgrove FP; Isaacson EI
    Tex Med; 1966 Aug; 62(8):91-2. PubMed ID: 5946342
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe hypoglycemic reaction with chlorpropamide in therapeutic dosage.
    LEVIN EB
    Calif Med; 1963 May; 98(5):279-80. PubMed ID: 13930105
    [No Abstract]   [Full Text] [Related]  

  • 35. Antidiuretic and hypoglycaemic activity.
    Knell AJ
    Br Med J; 1971 Mar; 1(5749):608. PubMed ID: 5548307
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tolazamide as an antidiabetic].
    Witte JJ
    Ned Tijdschr Geneeskd; 1967 Feb; 111(5):215-8. PubMed ID: 5342766
    [No Abstract]   [Full Text] [Related]  

  • 37. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged and recurrent tolazamide-induced hypoglycemia. Report of a case.
    Rull JA; Lennhoff M
    Diabetes; 1967 May; 16(5):352-3. PubMed ID: 6022563
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on the blood clearance and urinary elimination of free and bound fractions of a delayed-action hypoglycemic sulfonamide and of a prolonged-action antibacterial sulonfamide simultaneously administered].
    Debry G; Badia
    Therapie; 1969; 24(1):145-53. PubMed ID: 5807417
    [No Abstract]   [Full Text] [Related]  

  • 40. CHLORPROPAMIDE-INDUCED HYPOGLYCEMIC COMA.
    VOGL A
    Postgrad Med; 1964 Oct; 36():400-3. PubMed ID: 14195808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.